Status:
RECRUITING
Analysis of Selected Biochemical Parameters in Cerebrospinal Fluid and Peripheral Blood in the Treatment of Neuropathic Pain Using Spinal Cord Stimulation (SCS)
Lead Sponsor:
Pawel Sokal
Collaborating Sponsors:
Department of Neurosurgery Collegium Medicum Nicolaus Copernicus University
Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz
Conditions:
Neuropathic Pain
Chronic Pain
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This project aims to identify key cells and molecules involved in the development and modulation of neuropathic pain treated with spinal cord stimulation (SCS). By measuring concentrations of selected...
Detailed Description
1. The Aim of the Project The aim of this project is to measure the concentrations of selected inflammatory mediators and other signalling molecules in the blood and cerebrospinal fluid (CSF) of p...
Eligibility Criteria
Inclusion
- Age 18-80
- PSPS or CRPS
- Neuropathic pain for at least 6 months
Exclusion
- Drug/alcohol addiction
- Malignant tumour
- Psychiatric disorders
- Active infection
- Pregnancy
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07153211
Start Date
November 1 2022
End Date
December 31 2026
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jan Bizel University Hospital
Bydgoszcz, Poland, 85-168